Literature DB >> 2580242

The dihydropyridine derivative, Bay K 8644, enhances insulin secretion by isolated pancreatic islets.

U Panten, S Zielmann, M T Schrader, S Lenzen.   

Abstract

The effects of the dihydropyridine derivative Bay K 8644 upon insulin secretion by perifused isolated mouse pancreatic islets were examined. At a non-stimulatory glucose concentration (5 mmol/l) Bay K 8644 (1 mumol/l) did not stimulate insulin release. However, the same drug concentration enhanced the insulin secretory responses to an intermediate (15 mmol/l) or high (30 mmol/l) glucose concentration by 80 or 90%, respectively. Bay K 8644 was half maximally effective at 0.1 mumol/l and maximally effective at 1 mumol/l. The results are compatible with the view that voltage-dependent calcium channels are essential for stimulus-secretion coupling in pancreatic B-cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580242     DOI: 10.1007/bf00515566

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  A versatile microperifusion system.

Authors:  U Panten; H Ishida; P Schauder; H Frerichs; A Hasselblatt
Journal:  Anal Biochem       Date:  1977-10       Impact factor: 3.365

2.  Effects of possible beta-cell membrane label, metahexamide-isothiocyanate, on insulin release.

Authors:  H G Joost
Journal:  Horm Metab Res       Date:  1979-02       Impact factor: 2.936

3.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

4.  Differential effects of Bay k 8644, a presumed calcium channel activator, on sinoatrial nodal and ventricular automaticity of the dog heart.

Authors:  K Satoh; Y Wada; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

5.  Recognition of insulin-releasing fuels by pancreatic B-cells: alpha-ketoisocaproic acid is an appropriate model compound to study the role of B-cell metabolism.

Authors:  U Panten; J Biermann; W Graen
Journal:  Mol Pharmacol       Date:  1981-07       Impact factor: 4.436

6.  Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine.

Authors:  P Erne; E Bürgisser; F R Bühler; B Dubach; H Kühnis; M Meier; H Rogg
Journal:  Biochem Biophys Res Commun       Date:  1984-02-14       Impact factor: 3.575

7.  Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.

Authors:  U Albus; E Habermann; D R Ferry; H Glossmann
Journal:  J Neurochem       Date:  1984-04       Impact factor: 5.372

8.  Effects of amino acids on membrane potential and 86Rb+ fluxes in pancreatic beta-cells.

Authors:  J C Henquin; H P Meissner
Journal:  Am J Physiol       Date:  1981-03

9.  The electrogenic sodium-potassium pump of mouse pancreatic B-cells.

Authors:  J C Henquin; H P Meissner
Journal:  J Physiol       Date:  1982-11       Impact factor: 5.182

10.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.

Authors:  S Kokubun; H Reuter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more
  3 in total

1.  Arsenite and its trivalent methylated metabolites inhibit glucose-stimulated calcium influx and insulin secretion in murine pancreatic islets.

Authors:  Madelyn Huang; Christelle Douillet; Miroslav Stýblo
Journal:  Arch Toxicol       Date:  2019-07-22       Impact factor: 5.153

2.  Dual effect of 1.4-dihydropyridines on Ca2+ inflow into rat pancreatic islet cells.

Authors:  P O Plasman; A Herchuelz; P Lebrun
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

3.  Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans.

Authors:  N G Morgan; C D Short; G M Rumford; W Montague
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.